美国林业发展局向印度制药公司Indoco发出警告,警告该公司Goa工厂的合规问题。 US FDA issues warning to Indian drug company Indoco over compliance issues at its Goa plant.

在7月的一次检查之后,印度制药公司Indoco Relief收到了美国林业发展局的一封警告信,警告该公司Goa工厂。 Indian pharmaceutical company Indoco Remedies received a warning letter from the US FDA for its Goa plant following a July inspection. 由于遵约问题,该厂以前被标记为采取官方行动。 The plant was previously marked for official action due to compliance issues. 尽管发出了警告,印度生态公司仍然致力于解决这些问题,并继续向美国市场供应产品。 Despite the warning, Indoco remains committed to resolving the issues and continues to supply products to the US market. 公司股份在宣布后略有增加。 The company's shares increased slightly after the announcement.